Healthpoint
Quick facts
Marketed products
- Bacitracin Ointment
- Collagenase SANTYL® Ointment
- Collagenase Santyl Vehicle · Wound Care / Dermatology
Collagenase enzymatically breaks down collagen in necrotic tissue, facilitating debridement of wounds. - Santyl · Other
- Tegaderm Hydrogel · Wound Care
Tegaderm Hydrogel is a moisture-donating wound dressing that maintains a moist healing environment by absorbing exudate and providing hydration to dry or necrotic tissue.
Phase 3 pipeline
- HP-802-247 · Oncology
HP-802-247 is a monoclonal antibody targeting CD47.
Phase 2 pipeline
- No HP802 Treatment
- Xenaderm · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Healthpoint
What are Healthpoint's marketed drugs?
Top marketed products include Bacitracin Ointment, Collagenase SANTYL® Ointment, Collagenase Santyl Vehicle, Santyl, Tegaderm Hydrogel.
What is Healthpoint's pipeline?
Healthpoint has 1 drugs in Phase 3, 2 in Phase 2, 0 in Phase 1. Late-stage candidates include HP-802-247.
Related
- Bacitracin Ointment
- Collagenase SANTYL® Ointment
- Collagenase Santyl Vehicle · Wound Care / Dermatology
- Santyl · Other
- Tegaderm Hydrogel · Wound Care
- Sector hub: All tracked pharma companies